- Home
- ARAI vs ICCM Comparison
ARAI vs ICCM Comparison
Compare ARAI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ARAI | ICCM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | Israel |
| Employees | 51 | N/A |
| Industry | Diversified Commercial Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 20.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ARAI | ICCM |
|---|---|---|
| Price | $0.27 | $3.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $2.50 |
| AVG Volume (30 Days) | ★ 482.4K | 83.1K |
| Earning Date | 04-15-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $800.66 | $139.51 |
| Revenue Next Year | $650.00 | $75.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.13 |
| 52 Week High | $7.24 | $9.54 |
Technical Indicators
Market Signals| Indicator | ARAI | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 29.41 | 45.88 |
| Support Level | N/A | $2.71 |
| Resistance Level | $0.63 | $5.69 |
| Average True Range (ATR) | 0.03 | 0.28 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 14.72 | 43.02 |
Price Performance
Historical ComparisonAbout ARAI Arrive AI Inc.
Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advance chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.